News

Latest News

View All

#PGDxStories: Gustavo Cerqueira, Ph.D.

“Our mission is my greatest motivation. I truly value the opportunity we have at PGDx to improve the lives of present and future cancer patients. This is not, and should not be, an easy task – nor should it be taken lightly.” — Gustavo Cerqueira, Ph.D. 

Adair Newhall of Greenspring Associates Interview Doug Ward, CEO of PGDx

Doug Ward is Chief Executive Officer of Personal Genome Diagnostics (PGDx), a Baltimore company empowering the fight against cancer by unlocking actionable information from the human genome. He has more than 25 years of experience within the diagnostic market, including leadership positions at top-tier molecular diagnostics and testing innovators such as Roche, GE Healthcare, Siemens…

PGDx to Develop Liquid Biopsy Companion Dx for Five Prime Therapeutics’ Drug Candidate

NEW YORK (GenomeWeb) – Personal Genome Diagnostics said today that it has entered a collaboration with Five Prime Therapeutics to develop a blood-based companion diagnostic assay for use with Five Prime’s investigational drug candidate, bemarituzumab.Under the agreement, PGDx is creating and validating a circulating tumor DNA test to identify the approximately 10…